RxDoctor Payments Data

Ashley Conklin

Family · Kalamazoo, MINPI 1528500998

Payments from drug & device makers

$1,197in general payments, 2019–2025

Across 47 payments — averaging $25.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$252
  • Novo Nordisk$183
  • Abbott$175
  • Pfizer$162
  • AbbVie$134
  • Amgen$59
  • plus $232 from 8 others

What the payments were for

  • Food & beverage$1,197100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,197 in reported general payments places this provider in the 70th percentile of 3,657 family providers in Michigan.

See all family providers in Michigan

Medicare billing

Part B allowed, 2024
$12,052
Medicare patients
119
Services billed
167

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide27$33,039
EliquisApixaban19$14,644
Atorvastatin Calcium143$2,367
Lantus SolostarInsulin Glargine,hum.Rec.Anlog17$1,626
Levothyroxine Sodium94$1,354
Bupropion XlBupropion Hcl21$1,044
Albuterol Sulfate HfaAlbuterol Sulfate32$1,037
Gabapentin41$1,037
Fentanyl12$997
Omeprazole70$891
Diclofenac Sodium ErDiclofenac Sodium11$814
Simvastatin58$780
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen22$742
Metformin Hcl55$699
Metoprolol Succinate38$622

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$162$14,64419 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,657 family providers in Michigan.

Other family in Kalamazoo

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →